Role of PET/CT in evaluation of post-therapeutic HCC - Sameh Soliman, Sherif
36,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

The purpose of this book is to highlight the role of PET/CT in evaluation of post-therapeutic hepatocellular carcinoma, hence guiding the clinician to proper management strategy. Our study included 35 patients (32 male and 3 female). All patients had history of local treatment of HCC; most of the cases were treated with TACE or RFA, TACE was the main non-operative therapy for large or advanced intrahepatic HCC, while RFA was the main non-operative therapy for small HCCs. The data in our study showed that PET/CT as a metabolic imaging modality could evaluate therapeutic effect and prognostic…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
The purpose of this book is to highlight the role of PET/CT in evaluation of post-therapeutic hepatocellular carcinoma, hence guiding the clinician to proper management strategy. Our study included 35 patients (32 male and 3 female). All patients had history of local treatment of HCC; most of the cases were treated with TACE or RFA, TACE was the main non-operative therapy for large or advanced intrahepatic HCC, while RFA was the main non-operative therapy for small HCCs. The data in our study showed that PET/CT as a metabolic imaging modality could evaluate therapeutic effect and prognostic value in patients with post therapeutic HCC and also can perform full body scanning in a single session and sensitively detect both primary and metastatic tumors.
Autorenporträt
Le Dr Sherif Sameh Soliman est spécialiste principal en radiologie au ministère de la santé et de la population, en Égypte.